66 results
8-K
PTPI
Petros Pharmaceuticals Inc
12 Jan 24
Changes in Registrant's Certifying Accountant
4:32pm
to achieve an appropriate segregation of duties; and (3) the Company lacking appropriate IT access related controls.
The Company provided EisnerAmper
424B3
PTPI
Petros Pharmaceuticals Inc
19 Sep 23
Prospectus supplement
4:36pm
, 3rd Floor
New York, New York 10036
973-242-0005
You may also access the documents incorporated by reference in this prospectus through our website
8-K
EX-10.1
kw0 xfg5g4mb3wxkg5
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
8-K
EX-99.1
mjowfb3 42
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
8-K
EX-99.1
k30320x2qh6z90qlhf
15 Nov 22
Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update
8:30am
POS AM
jypufug mjk63
14 Oct 22
Prospectus update (post-effective amendment)
4:05pm
PRE 14A
yfxb6i79ib
30 Sep 22
Preliminary proxy
4:45pm